Neurophet appoints neuroradiologist Tanenbaum as scientific advisor
Neurophet, an AI company developing neuroimaging analysis software, has appointed neuroradiologist Lawrence Tanenbaum, MD, as scientific advisor. Tanenbaum brings more than 30 years of experience across clinical practice, academic research, and healthcare technology.
Tanenbaum most recently served as vice president and chief technology officer at RadNet, where he led imaging technology strategy and AI integration across a national imaging network. Before that, he was director of MRI, CT, and advanced imaging at the Icahn School of Medicine at Mount Sinai in New York City, where he also held the rank of associate professor of radiology.
He is a fellow of the American College of Radiology and has held advisory roles at more than 20 AI and imaging companies. He previously served on the Roster of Distinguished Scientific Advisors for the Radiological Society of North America.
Neurophet's product portfolio
Neurophet's software addresses specific clinical needs in neuroimaging analysis:
- Brain MRI analysis software
- PET image quantitative analysis tools
- Alzheimer's disease treatment monitoring software
- Multiple sclerosis image analysis tools
The company recently received FDA clearance for an updated version of its brain MRI analysis software, Neurophet Aqua AD Plus.
For those working in medical AI research and development, understanding how established clinical experts evaluate these tools can inform your own work in AI for Healthcare and AI for Science & Research.
Your membership also unlocks:
